Showing results (861-870 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|March 8, 2005
Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapySonja Offner, Armin Hekele, Ulrike Teichmann, et al.Cancer Immunology, Immunotherapy : CII|March 8, 2005
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatmentPhilipp Schütt, Ulrike Buttkereit, Dieter Brandhorst, et al.Cancer Immunology, Immunotherapy : CII|July 21, 2005
Spontaneous elicitation of potent antitumor immunity and eradication of established tumors by administration of DNA encoding soluble transforming growth factor-beta II receptor without active antigen-sensitizationKeiichi Kontani, Kiichi Kajino, Cheng-Long Huangi, et al.Cancer Immunology, Immunotherapy : CII|July 22, 2005
Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?Øystein Bruserud, Karl Johan Tronstad, Emmet McCormack, et al.Cancer Immunology, Immunotherapy : CII|July 22, 2005
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patientsJ B A G Haanen, A Baars, R Gomez, et al.Cancer Immunology, Immunotherapy : CII|July 13, 2005
T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expressionJonathan A Claus, Michael T Brady, Jaewoo Lee, et al.Cancer Immunology, Immunotherapy : CII|July 13, 2005
Tumor antigen-specific T helper cells in cancer immunity and immunotherapyK L Knutson, M L DisisCancer Immunology, Immunotherapy : CII|September 10, 2005
Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patientsNicholas F S Watson, Lindy G Durrant, Zahra Madjd, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Induction of antitumor activities in spleen cells from mice and rats activated with lipopolysaccharide immobilized on beadsH Abe, T Tani, J Shibata, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
The loss of class II MHC antigen expression by ras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cellsA G Morris, R L Darley, W J BatemanPageof 650